Definitions
Sorry, no definitions found. You may find more data at daclizumab.
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word Daclizumab.
Examples
-
Daclizumab also reduced the number of lesions from the disease and lowered the risk of sustained disability progression by 57% in the higher dose and 43% in the lower dose, compared to placebo and using a standard measurement.
Biogen, Abbott MS Drug Shows Effectiveness Thomas Gryta 2011
-
"Daclizumab is a promising treatment for multiple sclerosis, a disease that has a significant unmet medical need, and has the potential to become an important treatment option for patients,"
Abbott to Buy Facet Biotech Jay Miller 2010
-
"Daclizumab is a promising treatment for multiple sclerosis, a disease that has a significant unmet medical need, and has the potential to become an important treatment option for patients,"
Abbott to Buy Facet Biotech Jay Miller 2010
-
"Daclizumab is a promising treatment for multiple sclerosis, a disease that has a significant unmet medical need, and has the potential to become an important treatment option for patients,"
Abbott to Buy Facet Biotech Jay Miller 2010
-
Daclizumab is a biologic for multiple sclerosis that we obtained through our acquisition of Facet last year.
Abbott Laboratories CEO Discusses Q4 2010 Earnings Call Transcript - Seeking Alpha 2011
-
Daclizumab is a biologic currently in phase III testing for multiple sclerosis, which is a multibillion-dollar market opportunity.
Just One Stock: The Healthcare Giant With a Low Multiple and Solid Yield - Seeking Alpha 2011
-
"Daclizumab was well tolerated in the CHOICE trial and significantly reduced MS activity in patients who were not responding to interferon beta."
-
Daclizumab is a humanized monoclonal antibody that binds to CD25, a high affinity receptor that is expressed at low levels on resting T cells, which are a type of immune cell, and at high levels on T cells that can become activated in response to autoimmune conditions such as MS.
-
Daclizumab treatment was generally well-tolerated.
-
Daclizumab is an investigational agent in clinical development for the treatment of MS under a collaboration between Facet and Biogen Idec.
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.